Search clinical trials for: Oral liquid formulation

Total 22436 results

Cerecin

Completed

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Alzheimer Disease

United States
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
University of Washington
Fogarty International Center of the National Institute of Health

Completed

Enteral Resuscitation Nepal (Pilot Study)

Burn Shock | Burn Body Region Unspecified

Nepal
Parc de Salut Mar
Food and Drug Administration (FDA)

Completed

Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan.

Healthy

Spain
University Hospital, Gentofte, Copenhagen

Completed

Incretin Effect in Patients With Psoriasis and Controls

Psoriasis Vulgaris
Applied Therapeutics, Inc.

Active, not recruiting

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency (INSPIRE)

Hereditary Neuropathy Caused by SORD Deficiency

United States, United Kingdom, Czechia, Italy
Takeda

Completed

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Healthy Volunteers

United States
CTI BioPharma
Covance

Completed

Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects

Healthy Subjects

United States
CTI BioPharma
Covance

Completed

To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects

Healthy

United States
Children's Mercy Hospital Kansas City

Terminated

Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients

Hypothyroidism | Trisomy 21

United States
Masonic Cancer Center, University of Minnesota

Terminated

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Cytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy Patients

United States
Bristol-Myers Squibb

Completed

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Healthy Volunteers

United Kingdom
Anavex Life Sciences Corp.
Anavex Australia Pty Ltd.; Anavex Germany GmbH

Completed

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome (EXCELLENCE)

Rett Syndrome

Canada, Australia, United Kingdom
Washington State University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters

Interaction | Endogenous Biomarkers

United States
Baylor College of Medicine

Completed

Selegiline to Zelapar Switch Study in Parkinson Disease Patients

Parkinson's Disease

United States
University of Illinois at Chicago

Completed

Hydration Dynamics and Influence of Beverage Composition

Dehydration | Hydration | Fluid Retention

United States
Institut de Recherches Internationales Servier
ADIR, a Servier Group company; Les Laboratoires Servier (L.L.S), Russia

Completed

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) (ALL)

Acute Lymphoblastic Leukemia

Russian Federation
Novo Nordisk A/S

Completed

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II

Healthy Volunteers; High Cholesterol

United States
University of Campinas, Brazil

Completed

Clinical Efficiency of Xanthan Hydrogels Containing Local Anesthetics Encapsulated in Nanostructured Lipid Carries

Local Anesthesia | Dental Trauma | Oral Cavity Disease

Brazil
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Head and Neck Cancer

United States, Puerto Rico, South Africa
Reckitt Benckiser Healthcare (UK) Limited
Premier Research Group plc

Completed

Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars

Stomatognathic Diseases | Tooth Diseases | Tooth, Impacted

United States
Janssen Research & Development, LLC

Completed

A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants

Healthy

United States
Applied Science & Performance Institute

Completed

Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels

Iron Deficiency (Without Anemia)

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Withdrawn

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Cancer
MedVadis Research Corporation

Completed

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Chronic Pain

United States
Syneos Health
US Specialty Formulations, LLC

Completed

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

SARS-CoV-2 (COVID-19)

New Zealand
Biogen

Completed

A Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB104 and Assess the Effect of Food on the Pharmacokinetics of BIIB104 Following Administration of a Single, Fixed, Oral Dose of BIIB104 in Healthy Participants

Healthy Volunteers

United States
SOFAR S.p.A.

Completed

Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment

Gastro Esophageal Reflux

Germany
Pierre Fabre Medicament
Biotrial

Completed

Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
GeneScience Pharmaceuticals Co., Ltd.

Completed

GS3-007a Oral Solution in Healthy Subjects

Healthy Subject

China
Antonios Likourezos

Completed

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

Pain

United States
University of California, San Diego
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Head and Neck Cancer | Head and Neck Neoplasms | Nasopharynx Cancer | Head and Neck Squamous Cell Carcinoma | Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | HNSCC | Hypopharynx Cancer | Cutaneous Squamous Cell Carcinoma | Lip SCC | Sinonasal Carcinoma

United States
Celldex Therapeutics

Terminated

A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Advanced Head and Neck Squamous Cell Carcinoma

United States
Tufts Medical Center

Terminated

Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

Constipation

United States
University Hospital Inselspital, Berne

Withdrawn

Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate (TSTS)

Healthy
Genentech, Inc.

Completed

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-9545 Following a Single Oral Dose (Part 1) and to Evaluate the Absolute and Relative Bioavailability of Oral Capsule Formulations of GDC-9545 (Part 2) in Healthy Female Subjects of Non-Childbearing Potential

Healthy Volunteers

United Kingdom
Liquid I.V.
Lipscomb University

Completed

Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males

Fluid Retention | Beverage Hydration Index | Hydration Status

United States
McGill University
McGill University Health Centre/Research Institute of the McGill University...

Enrolling by invitation

Characterizing the Inflammation Around Dental Implants

Hypersensitivity | Peri-Implantitis | Peri-implant Mucositis | Implant Site Reaction | Implant Site Infection | Implant Infection | Implant Site Rash

Canada
AstraZeneca

Completed

To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours

Solid Tumours

Denmark, Belgium, United Kingdom, Netherlands
Alexandria University

Completed

Lubiprostone for Functional Constipation in the Under 18 Years Patients

Drug Side Effect | Treatment Efficacy | Clinical Efficacy

Egypt
XWPharma

Completed

Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers

Healthy

Australia
Dignity Sciences Ltd.

Completed

Oral DS107 in Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Guangzhou Blood Center

Completed

Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation

Blood Donation

China
Ege University
Karolinska Institutet

Completed

Menopause and Oral Health

Periodontal Diseases | Menopause

Turkey
Boehringer Ingelheim

Completed

A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood

Healthy

Germany
Novo Nordisk A/S

Completed

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Type 2 Diabetes | Healthy Volunteers

Germany
Vifor (International) Inc.

Completed

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Healthy

United Kingdom
Endocrinology Research Centre, Moscow
Russian Science Foundation

Completed

Vitamin D Metabolism in Patients With Endocrine Disorders

Diabetes Mellitus, Type 1 | Primary Hyperparathyroidism | Acromegaly | Pituitary ACTH Hypersecretion

Russian Federation
Italfarmaco

Completed

Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

Drug-Drug Interaction

Portugal
Defined Research

Active, not recruiting

Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia

Insomnia

United States

Search clinical trials for: Oral liquid formulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations